Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
Completed · Phase 3
Conditions studied: Major Depressive Disorder
In brief
This study is to evaluate that (SEROQUEL®) quetiapine sustained-release is efficacious and safe in the treatment of patients with MDD.
Key facts
- Study ID
- NCT00320268
- Run by
- AstraZeneca
- People needed
- 600
- Starts
- 2006-04-01
- Expected to finish
- 2007-05-01
- Last updated by the study team
- 2009-03-25
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient has a documented clinical diagnosis of Major Depressive Disorder.
- Be able to understand and comply with the requirements of the study.
- Able to understand and provide written informed consent
You may not qualify if…
- Patients (female) must not be pregnant or lactating
- Current or past diagnosis of stroke or transient ischemic attack (TIA).
Where it is running
- Research Site — Little Rock, Arkansas, United States
- Research Site — Newport Beach, California, United States
- Research Site — Northridge, California, United States
- Research Site — Oceanside, California, United States
- Research Site — Santa Ana, California, United States
- Research Site — Denver, Colorado, United States
- Research Site — Norwich, Connecticut, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Jacksonville, Florida, United States
- Research Site — Winter Park, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Smyrna, Georgia, United States
- Research Site — Eagle, Idaho, United States
- Research Site — Oak Brook, Illinois, United States
- Research Site — Wichita, Kansas, United States
- Research Site — Shreveport, Louisiana, United States
- Research Site — Farmington Hills, Michigan, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Las Vegas, Nevada, United States
- Research Site — Cherry Hill, New Jersey, United States
- Research Site — Clementon, New Jersey, United States
- Research Site — Brooklyn, New York, United States
- Research Site — New York, New York, United States
- Research Site — Staten Island, New York, United States
- Research Site — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.